Back to Authors

Rosen, Galit

A5108516942 | I4405271706

Mayo Clinic

Syndax Pharmaceuticals (United States)

Citations 2

P561: REVUMENIB IN PATIENTS WITH ACUTE LEUKEMIAS: COMPASSIONATE USE PROGRAM EXPERIENCE

HemaSphere | August 22, 2023 | Volume: 7 | Issue: S3 | Pages: e221187f

10.1097/01.hs9.0000969148.22118.7f

Outcomes after Transplant in Relapsed/Refractory KMT2Ar (MLLr) and mNPM1 (NPM1c) leukemia Patients Achieving Remissions after Menin Inhibition: SNDX-5613 (revumenib) Ph1 Experience

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 914-916

10.1182/blood-2022-164600